Jasper Therapeutics (NASDAQ:JSPR) Now Covered by Evercore ISI

Investment analysts at Evercore ISI assumed coverage on shares of Jasper Therapeutics (NASDAQ:JSPR – Get Free Report) in a note issued to investors on Wednesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $65.00 price target on the stock. Evercore ISI’s price target would indicate a potential upside of 136.02% from the stock’s […]

Related Keywords

Canada , ,Renaissance Technologies ,Nasdaq ,Gries Financial ,Jasper Therapeutics Inc ,Royal Bank ,Securities Exchange Commission ,Charles Schwab Investment Management Inc ,Jasper Therapeutics ,Get Free Report ,Velan Capital Investment Manag ,Exchange Commission ,Street Corp ,Schwab Investment Management ,Two Sigma Investments ,Jasper Therapeutics Daily ,Nasdaq Jspr ,Jspr ,Medical ,Initiated Coverage ,Evercore Isi ,